Literature DB >> 27223158

Postmenopausal Osteoporosis.

Karl Michaëlsson1, Per Aspenberg2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27223158      PMCID： PMC5104560          DOI： 10.1056/NEJMc1602599

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Risk of atypical femoral fracture during and after bisphosphonate use.

Authors:  Jörg Schilcher; Veronika Koeppen; Per Aspenberg; Karl Michaëlsson
Journal:  N Engl J Med       Date:  2014-09-04       Impact factor: 91.245

2.  Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.

Authors:  Dennis M Black; Ann V Schwartz; Kristine E Ensrud; Jane A Cauley; Silvina Levis; Sara A Quandt; Suzanne Satterfield; Robert B Wallace; Douglas C Bauer; Lisa Palermo; Lois E Wehren; Antonio Lombardi; Arthur C Santora; Steven R Cummings
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

Review 3.  Clinical Practice. Postmenopausal Osteoporosis.

Authors:  Dennis M Black; Clifford J Rosen
Journal:  N Engl J Med       Date:  2016-01-21       Impact factor: 91.245

4.  A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base.

Authors:  E McCloskey
Journal:  Osteoporos Int       Date:  2015-11-13       Impact factor: 4.507

5.  Overdiagnosis of bone fragility in the quest to prevent hip fracture.

Authors:  Teppo L N Järvinen; Karl Michaëlsson; Jarkko Jokihaara; Gary S Collins; Thomas L Perry; Barbara Mintzes; Vijaya Musini; Juan Erviti; Javier Gorricho; James M Wright; Harri Sievänen
Journal:  BMJ       Date:  2015-05-26
  5 in total
  2 in total

1.  Deep Radiomics-based Approach to the Diagnosis of Osteoporosis Using Hip Radiographs.

Authors:  Sangwook Kim; Bo Ram Kim; Hee-Dong Chae; Jimin Lee; Sung-Joon Ye; Dong Hyun Kim; Sung Hwan Hong; Ja-Young Choi; Hye Jin Yoo
Journal:  Radiol Artif Intell       Date:  2022-05-25

Review 2.  Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis.

Authors:  Safoora Poorirani; Sayed Latif Taheri; Sayed Abolfazl Mostafavi
Journal:  Osteoporos Int       Date:  2022-10-15       Impact factor: 5.071
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.